Niraja Nelogi
Dermatology and Aesthetic physician. INDIA
Title: Efficacy of platelet-rich plasma (PRP) therapy in androgenetic alopecia (AGA)
Biography
Biography: Niraja Nelogi
Abstract
Androgenetic alopecia is a genetic disorder, androgen-dependent progressive thinning of the scalp hair in men, also seen in women. It begins by 20 years of age and affects nearly 50% of men by the age of 50 years. PRP is one of the treatments for AGA which has shown significant improvement in the hair density.
PRP represents an autologous concentration of human platelets in a small volume of plasma having 4-7 times the platelet concentration above the normal blood. It is injected subcutaneously into the area of alopecia. PRP induce the proliferation of dermal papillae cells of the scalp and thereby increase the volume of the hair. PRP can be given to males and females of an age group of 18-70yrs having mild to moderate AGA. Therapy can be given at an interval of 4 weeks over a period of 3 months and the results are assessed, there is a significant clinical improvement of hair count, hair thickness, hair root strength, and alopecia patch. To conclude PRP is a simple, safe, non-allergic, cost-effective and feasible treatment for hair loss and adjuvant therapy in the management of AGA.